>TOP >Advantages of Evec >Patent


Patent on our antibodies

While the method to develop antibodies using EB virus has been known for a long time, successful materialization of the technique is very rare. We devised our unique technique to stably develop target antibodies by accumulating the know-how of preparing high-titer EB virus, culture and cloning of EB-virus-infected lymphocytes, and sorting lymphocytes producing antibodies of particular interest. Our antibodies can be a subject for substance patent. To this date, 11 patent applications have been made.

  • We are seeking Alliance partners
  • Inquiries by the media and press
  • Contract services. click here
  • EVEC, Inc.
    Taijuseimei-Odori Bldg 8F,
    Odori W6,Chuo-ku,Sapporo
    Postal code 060-0042
    Email info@evec.jp
  • Minister Award for Science, Technology and Innovation Policy of Japan